quinacrine has been researched along with Dysgammaglobulinemia in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Dysgammaglobulinemia: An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahmoud, AA | 1 |
| Warren, KS | 1 |
1 other study available for quinacrine and Dysgammaglobulinemia
| Article | Year |
|---|---|
Algorithms in the Diagnosis and Management of Exotic Diseases. ii. Giardiasis.
Topics: Diarrhea; Dysgammaglobulinemia; Giardia; Giardiasis; Humans; Malabsorption Syndromes; Quinacrine | 1975 |